A detailed history of Cetera Investment Advisers transactions in Abbott Laboratories stock. As of the latest transaction made, Cetera Investment Advisers holds 381,423 shares of ABT stock, worth $43.8 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
381,423
Previous 414,828 8.05%
Holding current value
$43.8 Million
Previous $43.1 Million 0.89%
% of portfolio
0.1%
Previous 0.1%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$100.07 - $118.13 $3.34 Million - $3.95 Million
-33,405 Reduced 8.05%
381,423 $43.5 Million
Q2 2024

Aug 22, 2024

SELL
$100.73 - $112.44 $5.59 Million - $6.24 Million
-55,470 Reduced 11.79%
414,828 $43.1 Million
Q1 2024

May 24, 2024

BUY
$109.52 - $120.96 $39.6 Million - $43.7 Million
361,132 Added 330.81%
470,298 $53.5 Million
Q1 2024

May 14, 2024

SELL
$109.52 - $120.96 $1.84 Million - $2.04 Million
-16,826 Reduced 13.35%
109,166 $12.4 Million
Q4 2023

Feb 13, 2024

SELL
$90.19 - $110.4 $262,272 - $321,043
-2,908 Reduced 2.26%
125,992 $13.9 Million
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $301,970 - $362,313
3,161 Added 2.51%
128,900 $12.5 Million
Q2 2023

Aug 09, 2023

SELL
$100.78 - $112.29 $367,443 - $409,409
-3,646 Reduced 2.82%
125,739 $13.7 Million
Q1 2023

May 15, 2023

SELL
$96.86 - $114.01 $837,645 - $985,958
-8,648 Reduced 6.27%
129,385 $13.1 Million
Q4 2022

Feb 14, 2023

SELL
$95.06 - $111.52 $42.4 Million - $49.7 Million
-445,931 Reduced 76.36%
138,033 $15.2 Million
Q3 2022

Nov 10, 2022

BUY
$96.76 - $112.03 $26.7 Million - $30.9 Million
276,106 Added 89.69%
583,964 $57,000
Q2 2022

Aug 11, 2022

SELL
$102.07 - $123.37 $48,789 - $58,970
-478 Reduced 0.16%
307,858 $33.4 Million
Q1 2022

May 13, 2022

BUY
$114.02 - $139.04 $321,422 - $391,953
2,819 Added 0.92%
308,336 $36.5 Million
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $186,118 - $227,892
1,611 Added 0.53%
305,517 $43 Million
Q3 2021

Nov 16, 2021

BUY
$116.66 - $129.06 $70,695 - $78,210
606 Added 0.2%
303,906 $35.9 Million
Q2 2021

Aug 13, 2021

BUY
$105.79 - $124.53 $698,425 - $822,147
6,602 Added 2.23%
303,300 $35.2 Million
Q1 2021

May 17, 2021

BUY
$108.84 - $128.23 $21.1 Million - $24.8 Million
193,414 Added 187.26%
296,698 $35.6 Million
Q4 2020

Feb 17, 2021

BUY
$105.0 - $114.42 $8.76 Million - $9.55 Million
83,425 Added 420.09%
103,284 $11.3 Million
Q3 2020

Nov 13, 2020

BUY
$91.64 - $111.29 $17,319 - $21,033
189 Added 0.96%
19,859 $2.16 Million
Q2 2020

Aug 13, 2020

SELL
$76.57 - $98.0 $117,381 - $150,234
-1,533 Reduced 7.23%
19,670 $1.8 Million
Q1 2020

May 08, 2020

BUY
$62.82 - $91.86 $67,782 - $99,116
1,079 Added 5.36%
21,203 $1.67 Million
Q4 2019

Feb 10, 2020

BUY
$78.51 - $87.4 $16,330 - $18,179
208 Added 1.04%
20,124 $1.75 Million
Q3 2019

Nov 06, 2019

SELL
$81.84 - $88.74 $63,262 - $68,596
-773 Reduced 3.74%
19,916 $1.66 Million
Q2 2019

Aug 12, 2019

BUY
$72.88 - $85.0 $133,661 - $155,890
1,834 Added 9.73%
20,689 $1.73 Million
Q1 2019

May 06, 2019

SELL
$66.22 - $80.06 $45,360 - $54,841
-685 Reduced 3.51%
18,855 $1.5 Million
Q4 2018

Feb 15, 2019

BUY
$65.56 - $74.27 $524 - $594
8 Added 0.04%
19,540 $1.41 Million
Q3 2018

Nov 14, 2018

BUY
$60.81 - $73.36 $133,599 - $161,171
2,197 Added 12.67%
19,532 $1.43 Million
Q2 2018

Aug 14, 2018

SELL
$57.57 - $63.54 $100,171 - $110,559
-1,740 Reduced 9.12%
17,335 $1.06 Million
Q1 2018

May 09, 2018

BUY
$56.27 - $63.62 $78,778 - $89,068
1,400 Added 7.92%
19,075 $1.14 Million
Q4 2017

Feb 08, 2018

BUY
$53.68 - $57.47 $91,578 - $98,043
1,706 Added 10.68%
17,675 $1.01 Million
Q3 2017

Nov 16, 2017

BUY
$48.06 - $53.64 $38,063 - $42,482
792 Added 5.22%
15,969 $851,000
Q2 2017

Aug 17, 2017

SELL
N/A
-12,438 Reduced 45.04%
15,177 $740,000
Q2 2017

Aug 14, 2017

BUY
N/A
27,615
27,615 $1.34 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.